Papers in Clinical Cancer Bulletin
Page 2 · newest first
- Causal associations of plasma proteins with lung squamous cell carcinoma risk: a proteome-wide Mendelian randomization and colocalization analysisClinical Cancer Bulletin · 2024
- MIR99AHG: a novel lncRNA host gene with diverse regulatory roles in cancerClinical Cancer Bulletin · 2024
- PANoptosis-based molecular subtype and prognostic model predict survival and immune landscape in esophageal cancerClinical Cancer Bulletin · 2024
- Spatial transcriptomics: a new frontier in cancer researchClinical Cancer Bulletin · 2024
- Microsatellite instability in gastric cancer: molecular features and clinical implicationsClinical Cancer Bulletin · 2024
- Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in advanced gastrointestinal cancer immunotherapy: evidence from published studies and a Chinese single center cohortClinical Cancer Bulletin · 2024
- Minimally invasive surgery is safe and effective for advanced HCC patients receiving perioperative adjuvant therapy: a real-world retrospective studyClinical Cancer Bulletin · 2024
- Progress, application and challenges of liver organoidsClinical Cancer Bulletin · 2024
- Perioperative immunotherapy for resectable non-small-cell lung cancerClinical Cancer Bulletin · 2024
- Lung cancer surgery: innovations and future perspectivesClinical Cancer Bulletin · 2024
- Innovative drugs promote precision cancer therapyClinical Cancer Bulletin · 2023
- The role of innate immune cells as modulators of the tumor microenvironment in the metastasis and treatment of pancreatic cancerClinical Cancer Bulletin · 2023
- Umbrella strategy with systemic and intraperitoneal chemotherapy versus systemic chemotherapy in patients with advanced gastric cancer: a multicenter, randomized Phase III clinical trialClinical Cancer Bulletin · 2023